HAS opinions and decisions
Les fiches de bon usage de médicaments intitulées :
- « Quelle place pour XOLAIR dans le traitement de l’asthme allergique sévère ? »,
- « Quelle place pour CINQUAERO et NUCALA dans le traitement de l’asthme allergique sévère ? »,
ci-jointes, sont adoptées.
See also
HAS opinions and decisions
29/08/2019
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
zkJmwuTVuvj8JEY4